A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial of Quizartinib Administered in Combination with Induction and Consolidation Chemotherapy and Administered as Maintenance Therapy in Adult Patients with Newly Diagnosed FLT3-ITD Negative Acute Myeloid Leukemia (QuANTUM-Wild)

Project: Research

Project Details

StatusActive
Effective start/end date21/08/25 → 20/08/27

Keywords

  • Clinical Trial
  • AC220-168

Clinical Trial Phase

  • Phase III (a & b)